CD86 and neoplasm: Specifically, we observed direct changes in the tumor microenvironment after using a ferroptosis inducer in this tumor subtype with the recruitment of CD3e+, CD4+, CD8+, and CD86+ cells, and a reduced number of CD206+ cells.